The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Merck has announced a second collaboration agreement in its Bioelectronics innovation field with Innervia Bioelectronics. The aim of the collaboration...
read more
AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the ...
read more
Sartorius acquired a majority stake in the reagent manufacturer CellGenix, a German producer and marketer of cell culture components including - ...
read more
Eurofins Scientific announced that its subsidiary Eurofins Clinical Testing US Holdings, Inc. agreed to acquire DNA Diagnostics Center (“DDC”), a ...
read more
The U.S. FDA approved Sanofi Pasteur, the vaccines business unit of Sanofi, for an additional influenza manufacturing facility located in Swiftwater, ...
read more
Amneal Pharmaceuticals Inc. announced that the U.S. FDA is reviewing the Biologics License Application (BLA) for Bevacizumab with a review date ...
read more
Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for prevalent diseases, will collaborate with Novo Nordisk. Lumen’s ...
read more
Linnaeus Therapeutics Inc., a privately-held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small ...
read more
Jounce Therapeutics Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers,...
read more
Bio-Thera Solutions Ltd., a commercial-stage pharmaceutical company, announced that dosing has begun in a Phase III clinical study for BAT2506, a ...
read more
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for 10 new projects in technology, ...
read more
NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced that the first patient has been dosed in the pilot study ...
read more
Subcutaneous administration of BCMAxCD3 T-cell redirecting bispecific antibody demonstrated clinical activity and a manageable safety profile ...
read more
Thursday, February 11, 2021
Zymo Research announced their COVID-19 Variant Sequencing Service.
read more
Omixon and SeqOnce Biosciences announce the launch of a new extension to the AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel ...
read more